Inventor · disambiguated record
Takeshi Matsuzaki
Also filed as: MATSUZAKI TAKESHI
9 granted patents·4 pending applications·72 citations·filing 1994–2013
85Inventor score
Top patents by PatentIndex Score
13 records- 0191US7846473B2Irinotecan preparationTERUMO CORP·Filed 2005·Granted Dec 7, 2010·18 cites·10 claims
- 0273US5958978ASpecific cyclooxygenase 2 inhibitor and anti-inflammatory agentYAKULT HONSHA KK·Filed 1996·Granted Sep 28, 1999·37 cites·2 claims
- 0366US7371773B2Breast cancer resistance protein (BCRP) inhibitorYAKULT HONSHA KK·Filed 2004·Granted May 13, 2008·2 cites·9 claims
- 0464US5601999AAntitumor polysaccharide-glycan complexesYAKULT HONSHA KK·Filed 1994·Granted Feb 11, 1997·9 cites·8 claims
- 0557US8945929B2Marker for determination of sensitivity to anti-cancer agentTANIGAWARA YUSUKE·Filed 2009·Granted Feb 3, 2015·1 cites·12 claims
- 0652US9174979B2Phenanthroindolizidine compound and NFκB inhibitor containing same as active ingredientIKEDA TAKASHI·Filed 2009·Granted Nov 3, 2015·0 cites·24 claims
- 0752US8569327B2Phenanthroindolizidine derivative and NFκB inhibitor containing same as active ingredientIKEDA TAKASHI·Filed 2009·Granted Oct 29, 2013·0 cites·20 claims
- 0851US2008287374A1Breast cancer-resistant protein inhibitorYAKULT HONSHA KK·Filed 2008·Application pending·0 cites
- 0946US2006135445A1Breast cancer-resistant protein inhibitorYAKULT HONSHA KK·Filed 2004·Application pending·0 cites
- 1043US2014343017A1Pyrrole compoundYAKULT HONSHA KK·Filed 2013·Application pending·0 cites
- 1142US5763673ADiarylheptanoide derivative and pharmaceutical composition comprising the sameYAKULT HONSHA KK·Filed 1995·Granted Jun 9, 1998·5 cites·5 claims
- 1241US8697742B2BCRP/ABCG2 inhibitorYAMAZAKI RYUTA·Filed 2006·Granted Apr 15, 2014·0 cites·12 claims
- 1339US2008193509A1Liposome Preparation Containing Slightly Water-Soluble CamptothecinTERUMO CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takeshi Matsuzaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →